Abstract:You have accessJournal of UrologyProstate Cancer: Basic Research V1 Apr 2014MP52-06 IN VITRO CO-CULTURE MODEL TO STUDY ADRENAL STIMULUS OF CRPC Jan Matthijs Moll, Wilma Teubel, Ian Hickson, Ralph Graeser, Guido Jenster, and Wytske van Weerden Jan Matthijs MollJan Matthijs Moll More articles by this author , Wilma TeubelWilma Teubel More articles by this author , Ian HicksonIan Hickson More articles by this author , Ralph GraeserRalph Graeser More articles by this author , Guido JensterGuido Jenster More articles by this author , and Wytske van WeerdenWytske van Weerden More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2014.02.1616AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail Introduction and Objectives Numerous studies have demonstrated the androgen receptor (AR) is still active in CPRC despite low serum testosterone levels. Among other mechanisms of AR-activation, intratumoural androgen synthesis, either via conversion of adrenal steroids or de novo synthesis from cholesterol, is a mechanism of castration resistance. Our group has previously demonstrated that clinical CRPC samples expressed markers for conversion of adrenal androgens and not for de novo synthesis. In this study, we compared growth stimulation of castration-naïve and CRPC cell lines by adrenal androgens (conversion) or androgen precursors (de novo synthesis) and subsequently tested a novel co-culture model to mimic adrenal stimulus of (CR)PC. Methods VCaP and DuCaP CRPC lines were generated by long-term culturing in androgen-depleted medium with or without the anti-androgens bicalutamide or flutamide. To test cell growth, VCaP and DuCaP cells and their CRPC sublines were cultured in the presence of androgen precursors (pregnenolone and progesterone) or adrenal androgens (DHEA and androstenedione) at levels found in men. Cultures were treated with vehicle, the CYP17A1-inhibitor Abiraterone (0.1 μM) or the anti-androgen MDV3100 (1 μM). Cell proliferation was assessed by MTT-assay on day 9 with each experiment performed in triplicate. For the co-culture system, VCaP cells were cultured with human adrenal (H295R) cells in separate compartments between which only medium, but not cells, could diffuse freely, and treated with vehicle, Abiraterone or R1881. Results In VCaP and DuCaP and their CRPC derivatives, androgen precursors pregnenolone and progesterone did not induce cell growth. Physiological levels of adrenal androgens stimulated cell growth, which was similar to optimal stimulus by DHT. Treatment with Abiraterone could not block adrenal androgen induced growth, while MDV3100 blocked steroid-induced growth in all conditions. Co-culturing of VCaP cells with H295R cells induced optimal cell growth, which could be inhibited by treatment with Abiraterone. Conclusions These data support our previous clinical observation that (CR)PC seems to rely more on conversion than on de novo androgen synthesis. Co-culturing PC cells with human adrenal cells using a 2-compartment system is a relevant model to test CRPC stimulation in vitro. © 2014FiguresReferencesRelatedDetails Volume 191 Issue 4S April 2014 Page: e582 Advertisement Copyright & Permissions© 2014Metrics Author Information Jan Matthijs Moll More articles by this author Wilma Teubel More articles by this author Ian Hickson More articles by this author Ralph Graeser More articles by this author Guido Jenster More articles by this author Wytske van Weerden More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...